+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The receptor for urokinase type plasminogen activator regulation of gene expression by growth factors and tumor promoters in human cell lines



The receptor for urokinase type plasminogen activator regulation of gene expression by growth factors and tumor promoters in human cell lines



Journal of Cellular Biochemistry Suppl. (16 Part F): 112




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033908948

Download citation: RISBibTeXText


Related references

Expression of insulin-like growth factors , the type I insulin-like growth factor receptor , urokinase type plasminogen activator and tissue type plasminogen activator in ovarian cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 44: 266, 2003

Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis. Journal of Urology 174(2): 461-465, 2005

Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines. Clinical Cancer Research 7(2): 267-276, 2001

Regulation of tissue type plasminogen activator gene expression the role of growth factors and tumor promoters. Haemostasis 16(Suppl. 5): 5-6, 1986

Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines. Febs Letters. 383(3): 139-144, 1996

Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors. Oncology Reports 26(6): 1555-1560, 2011

Phorbol-ester-stimulated human lymphoid cell lines produce a plasminogen activator modulator inducing cell-bound urokinase-type plasminogen activator in malignant tumor cell lines. International Journal of Cancer 65(2): 178-185, 1996

Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines. Molecular and Cellular Endocrinology 61(1): 87-96, 1989

Tumor necrosis factor alpha regulates messenger rna for urokinase type plasminogen activator and type 1 plasminogen activator inhibitor in human neoplastic cell lines. Molecular & Cellular Endocrinology 61(1): 87-96, 1989

A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. Journal of Biological Chemistry 263(5): 2358-2363, 1988

Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells. Oncology Reports 17(5): 1259-1268, 2007

Growth factor modulation of urokinase-type plasminogen activator and its receptor in MDA-MB-231 and S30 human breast cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 37: 92, 1996

Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity. International Journal Of Cancer. 71(5): 867-873, 1997

Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines. Clinical Cancer Research 7(4): 1087-1093, 2001

Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease. Annals of Surgical Oncology 10(8): 948-953, 2003